Biotech: The Ultimate Impact Investment? | TIGER 21 Chair Featured in Financial Times
Orlando TIGER 21 Chair Eric Casaburi was recently featured in the Financial Times, where he shared his insights on how the ultra-high-net-worth community is currently approaching biotech investing and the tremendous movement into the healthcare space. A survey of TIGER 21 Members found that nearly 25% planned to invest in healthcare this year.
The emphasis on healthcare is reflected in the flow of family office money into venture capital. Despite the potential risk if a treatment does not work, the rewards in healthcare can be substantial, making it an impact investment.